Home
Contact Us
Site Map
Search
Mission & Vision
Board of Directors
Executive Management
Collaborations
Company
|
Date
|
Type
Lilly
12/11
Access to TAP technology
Novartis
10/10
Access to TAP technology
Amgen
11/09
Right to use TAP technology
9/09
Right to use TAP technology
9/00
Access to TAP technology
Genentech*
12/08
Right to use TAP technology
12/05
Right to use TAP technology
7/05
Right to use TAP technology
4/05
Right to use TAP technology
Bayer HealthCare Pharmaceuticals
10/08
Right to use TAP technology
Sanofi
8/08
Exercise of Option for Expanded Access to ImmunoGen's TAP Technology
; renewal option exercised
10/06
License for Broader Access to ImmunoGen's Humanization Technology
8/06
Second extension of 7/03 research collaboration; release of ImmunoGen from presenting targets
7/03
Research, development, and commercialization collaboration
Biotest
7/06
Right to use TAP technology; ImmunoGen has opt-in rights
Genentech
5/06
ImmunoGen to develop commercial-scale manufacturing process for T-DM1; amendment of 5/00 HER2 agreement
5/00
Right to use TAP Technology
*Genentech, Inc. is a member of the Roche Group.
© 2012 ImmunoGen, Inc.
|
Privacy Policy
|
Usage Policy
Last updated December 30, 2011
